How did the £700m Targeted Investment Fund impact national elective care performance?


We produced a comprehensive interim report that enabled NHS England to assess whether anticipated benefits were delivered.


NHS England wanted to understand what proportion of the £700m Targeted Investment Fund that had been allocated to systems for elective schemes in 2021/22 had been spent. And whether the predicted benefits had been achieved or were predicted to meet planned levels. We were chosen to partner with them to collate, analyse and evaluate the impact of the schemes.


What we did

We mobilised a multi-disciplinary team which included a programme manager, a financial expert, and a designer, to conduct the evaluation and deliver a final report.

By taking over management of the monthly returns process we were able to configure the final month’s template to ensure that regions got clear feedback on their scheme’s status and the actual/predicted benefits achieved. Our changes led to an improved process for collecting future returns.

The final report delivered to the national team presented a comprehensive picture outlining each region’s financial status and the benefits resulting from the scheme.



  • We supported the National Elective Care transformation team to deliver a detailed report outlining the evaluation of each region’s scheme in a challenging timescale.
  • The improved quality and reliability of the data in the final report provided assurance on the current position to inform decision-making.
  • Using the tools and processes we developed future stages of the programme will benefit from the Improvements in data quality and collection efficiency.
To find out more, please contact our Programme Manager, Transformation, This email address is being protected from spambots. You need JavaScript enabled to view it..

More case studies